Ahmad Ebadi

621 total citations
50 papers, 484 citations indexed

About

Ahmad Ebadi is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Ahmad Ebadi has authored 50 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Organic Chemistry and 19 papers in Computational Theory and Mathematics. Recurrent topics in Ahmad Ebadi's work include Computational Drug Discovery Methods (19 papers), Synthesis and biological activity (12 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Ahmad Ebadi is often cited by papers focused on Computational Drug Discovery Methods (19 papers), Synthesis and biological activity (12 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Ahmad Ebadi collaborates with scholars based in Iran, Germany and France. Ahmad Ebadi's co-authors include Nima Razzaghi‐Asl, Ramin Miri, Dara Dastan, Saghi Sepehri, Maryam Salami, Thomas Haertlé, Mohammad Reza Ehsani, Saeed Balalaie, A. Niasari-Naslaji and Ali Akbar Moosavi‐Movahedi and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Ahmad Ebadi

45 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmad Ebadi Iran 12 219 147 101 96 87 50 484
Sushma Pradeep India 16 168 0.8× 126 0.9× 184 1.8× 55 0.6× 93 1.1× 52 683
Muhammed Tılahun Muhammed Türkiye 13 326 1.5× 296 2.0× 231 2.3× 67 0.7× 73 0.8× 67 788
Valentina Noemi Madia Italy 18 288 1.3× 284 1.9× 56 0.6× 61 0.6× 132 1.5× 39 802
Khattab Al-Khafaji Türkiye 15 263 1.2× 125 0.9× 206 2.0× 39 0.4× 57 0.7× 32 648
Shah Faisal Pakistan 9 150 0.7× 119 0.8× 71 0.7× 48 0.5× 59 0.7× 17 480
Priyanshu Bhargava Japan 15 270 1.2× 59 0.4× 60 0.6× 122 1.3× 60 0.7× 23 723
Vivitri Dewi Prasasty Indonesia 14 205 0.9× 46 0.3× 87 0.9× 52 0.5× 73 0.8× 74 607
Dev Bukhsh Singh India 13 215 1.0× 54 0.4× 124 1.2× 36 0.4× 59 0.7× 45 500
Muhammad Nasir Iqbal Pakistan 11 170 0.8× 74 0.5× 113 1.1× 27 0.3× 40 0.5× 47 475
Arun Bahadur Gurung India 15 293 1.3× 145 1.0× 293 2.9× 41 0.4× 84 1.0× 46 749

Countries citing papers authored by Ahmad Ebadi

Since Specialization
Citations

This map shows the geographic impact of Ahmad Ebadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Ebadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Ebadi more than expected).

Fields of papers citing papers by Ahmad Ebadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Ebadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Ebadi. The network helps show where Ahmad Ebadi may publish in the future.

Co-authorship network of co-authors of Ahmad Ebadi

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Ebadi. A scholar is included among the top collaborators of Ahmad Ebadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Ebadi. Ahmad Ebadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hariri, Roshanak, Mina Saeedi, Somayeh Mojtabavi, et al.. (2025). Design, synthesis, and investigation of novel 5-arylpyrazole-glucose hybrids as α-glucosidase inhibitors. Scientific Reports. 15(1). 9912–9912.
2.
3.
Ebadi, Ahmad, et al.. (2024). Synthesis of Novel 3,4‐Dihydropyrimidine Derivatives, Cytotoxic Activity Evaluation, Apoptosis, Molecular Docking Studies, and MD Simulations. Chemistry & Biodiversity. 22(1). e202402170–e202402170. 3 indexed citations
4.
Sepehrmansourie, Hassan, Ahmad Ebadi, Mohammad Ali Zolfigol, et al.. (2024). Novel coumarin-based acetohydrazide-1,2,3-triazole derivatives as urease enzyme inhibitors: Synthesis, in vitro evaluation, and molecular dynamics simulation studies. Heliyon. 11(1). e41321–e41321. 2 indexed citations
5.
6.
Ebadi, Ahmad, Ardeshir Khazaei, Mohammad Ali Faramarzi, et al.. (2023). Novel Pyrano[3,2-c]quinoline-1,2,3-triazole Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Molecular Dynamics Simulation. ACS Omega. 8(26). 23412–23424. 15 indexed citations
7.
Ebadi, Ahmad, et al.. (2023). Ferulago bernardii as a New Source of α‐Pinene Binds to ctDNA: In Silico and in Vitro Studies. Chemistry & Biodiversity. 20(12). e202301302–e202301302. 1 indexed citations
8.
Sabahi, Mohammadmahdi, et al.. (2023). Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling. European Journal of Pharmacology. 941. 175517–175517. 7 indexed citations
9.
10.
Ebadi, Ahmad, et al.. (2023). Simulational and theoretical study of electron scattering cross section by Chlormethine-DNA complex. Physica Scripta. 98(12). 125405–125405. 1 indexed citations
11.
Sarihi, Abdolrahman, et al.. (2023). In silico molecular modeling, neuro-behavioral profile, and toxicity assessment of the essential oil of Ferula gummosa Boiss. as an anti-seizure agent. Journal of Ethnopharmacology. 309. 116347–116347. 5 indexed citations
12.
Ebadi, Ahmad, et al.. (2023). In silico repurposing of CNS drugs for multiple sclerosis. Multiple Sclerosis and Related Disorders. 73. 104622–104622. 3 indexed citations
13.
Dastan, Dara, et al.. (2022). An arginine-rich peptide inhibits AChE: template-based design, molecular modeling, synthesis, and biological evaluation. Journal of Molecular Modeling. 28(4). 86–86. 2 indexed citations
14.
Moosavi, Fatemeh, et al.. (2021). Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives. European Journal of Pharmacology. 894. 173850–173850. 20 indexed citations
15.
Ebadi, Ahmad, et al.. (2020). Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics. 39(17). 6633–6648. 23 indexed citations
16.
Razzaghi‐Asl, Nima, et al.. (2018). The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor. Computational Biology and Chemistry. 77. 307–317. 12 indexed citations
17.
Ebrahimi, Mohsen, Omidreza Firuzi, Ramin Miri, Nima Razzaghi‐Asl, & Ahmad Ebadi. (2016). Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2. Interdisciplinary Sciences Computational Life Sciences. 10(2). 400–410. 3 indexed citations
18.
Ebadi, Ahmad, Nima Razzaghi‐Asl, Mehdi Khoshneviszadeh, & Ramin Miri. (2013). Comparative amino acid decomposition analysis of potent type I p38α inhibitors. DARU Journal of Pharmaceutical Sciences. 21(1). 41–41. 6 indexed citations
19.
Razzaghi‐Asl, Nima, et al.. (2012). Response surface methodology in docking study of small molecule BACE-1 inhibitors. Journal of Molecular Modeling. 18(10). 4567–4576. 13 indexed citations
20.
Razzaghi‐Asl, Nima, et al.. (2012). Ab initio modeling of a potent isophthalamide-based BACE-1 inhibitor: amino acid decomposition analysis. Medicinal Chemistry Research. 22(7). 3259–3269. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sushma Pradeep Breakdown of academic impact, for papers by Muhammed Tılahun Muhammed Breakdown of academic impact, for papers by Valentina Noemi Madia Breakdown of academic impact, for papers by Khattab Al-Khafaji Breakdown of academic impact, for papers by Shah Faisal Breakdown of academic impact, for papers by Priyanshu Bhargava Breakdown of academic impact, for papers by Vivitri Dewi Prasasty Breakdown of academic impact, for papers by Dev Bukhsh Singh Breakdown of academic impact, for papers by Muhammad Nasir Iqbal Breakdown of academic impact, for papers by Arun Bahadur Gurung
Rankless by CCL
2026